当前位置：药药网 / 医药文献 /临床试验药物安全性(本栏目收费,不能显示细节,电话13136136841)
关键字：
类型：
下载页码(大于0,小于852)：
临床试验药物安全性 1506条(本栏目收费,不能显示细节,电话13136136841)
Form 483 notice,722,724
722 724
on adverse events that appear irrelevant to the study drug,541,542
541 542
in approving a drug,808
808
in assessing causality,525
525
in evaluating adverse events,518,519
518 519
Black box warning,694,695
694 695
allocation concealment versus blinding,137,139
137 139
Blood brain barrier,627
627
Blumenschein schema,45,46
45 46
for hepatitis C virus,78,79
78 79
Corroborative treatment effect,247,248
247 248
adverse event classification,495,496
495 496
C-reactive protein (CRP)biochemistry,394,397
394 397
biomarker applications atherosclerosis,398,400
398 400
C-reactive protein levels,390
390
health-related quality of life,473
473
immune response,615,616
615 616
CTCAE dictionary adverse event severity grading,530,532
530 532